0NWK.L
VALERIO THERAPEUTICS VALERIO TH
£0.19
-1.71%
2026-05-29
About VALERIO THERAPEUTICS VALERIO TH
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody drug conjugates, and chimeric antigen receptors. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.
Key Fundamentals
EPS (TTM)
£-0.07
Revenue Growth (YoY)
43.6%
Profit Margin
-190.4%
Debt/Equity
400.43
Price/Book
47.50
Beta
1.76
Market Cap
£8.3M
Avg Volume (10D)
9K
Recent Breakout Signals
No recent breakout signals detected for 0NWK.L.
Recent Price Range (60 Days)
60D High
£0.22
60D Low
£0.11
Avg Volume
12K
Latest Close
£0.19
Get breakout alerts for 0NWK.L
Sign up for Breakout Scanner to receive daily notifications when 0NWK.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
VALERIO THERAPEUTICS VALERIO TH (0NWK.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0NWK.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.